Choose Your News
Loading...
AstraZeneca's blockbuster potential lupus treatment failed in a late-stage study, the Cambridge, England-based drugmaker said Friday. The news is a blow to AstraZeneca's effort to... [Read More]
Weekly review: The S&P 500 hit new highs on a U.S.-Mexico trade deal. Lululemon earnings leapt as retail results were mixed. Marijuana stocks were big... [Read More]
United Airlines on Friday raised its baggage fee for checked luggage following JetBlue's decision earlier in the week to do the same, as higher fuel... [Read More]
Lockheed Martin is reportedly shopping around a F-35/F-22 hybrid concept, as the Pentagon begins work on a 6th-generation fighter that could take decades to develop... [Read More]
Boeing beat out Lockheed Martin and General Atomics to build the MQ-25 Navy refueling drone, potentially worth billions of dollars over the life of the... [Read More]
The decision by Ford to scrap plans to import its small Focus Active passenger car from China due to Trump tariffs is an early loss... [Read More]
The cards were stacked against Rebecca Lukens when she honored her husband's deathbed request and took over the Brandywine Iron Works & Nail Factory in... [Read More]
Biotech funds saw $510 million in net inflows this week, as assets increased for the eighth week running, an analyst said Friday. [Read More]
Wall Street analysts hit Electronic Arts stock with a volley of price-target cuts Friday after the video game publisher postponed the release of its big... [Read More]
Integrated Device Technology shares jumped to a 17-year high on Friday on reports that Japan's Renesas Electronics is looking to buy the U.S. chipmaker. [Read More]
Companies that are looking to up their game with better technology efficiency in an increasingly complex digital world are signing up with ServiceNow, a leader... [Read More]
David Rae is harnessing the power of niche marketing to grow the financial advisory firm he launched last summer. [Read More]
Dow Jones component Merck gained approval late Thursday of two new HIV treatments about two months ahead of schedule. The drugs are named Delstrigo and... [Read More]
Eagle Pharmaceuticals plunged Thursday — diving below a flat base — after enrolling just a tenth of the 70 patients it expected for a study of its... [Read More]
Apple stock surged to an all-time high after the consumer electronics giant announced a Sept. 12 event, presumably to reveal its latest iPhones and other... [Read More]
Hedge fund billionaire Leon Cooperman is investing in Chicago-based cannabis cultivator Green Thumb Industries, making him the latest big investor in marijuana stocks. [Read More]
Ulta Beauty earnings are on tap late Thursday. The beauty products retailer is expected to report a 16% sales gain, which would be the slowest... [Read More]
Nutanix stock fell after the market close Thursday after the technology company reported quarterly results that topped estimates. [Read More]
Ambarella, a maker of video compression, image processing and computer vision chips, late Thursday reported fiscal second-quarter results that beat Wall Street's targets. But its sales... [Read More]
Dow Jones component Pfizer scrapped a pair of studies in Duchenne muscular dystrophy — prodding shares of rivals Sarepta Therapeutics and Solid Biosciences to jump. [Read More]
Loading...
Preview